Clinical Trial Update: A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating GK01 Injection in adults with advanced malignant solid tumors; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• GK01 Injection

Snippet

Sponsor: Beijing Geekgene Technology Co., LTD | Conditions: Advanced Solid Tumors | Phase 1 | Status: NOT_YET_RECRUITING